-

Eurofins Adds Virus Variant Detection to its SARS-CoV-2 Monitoring Solution for Wastewater, Surface, Air and Worn Masks

LUXEMBOURG--(BUSINESS WIRE)--Eurofins (Paris:ERF) adds virus variant monitoring capabilities to its commercially available SARS-CoV-2 test portfolio. This new solution is part of the Eurofins COVID-19 Sentinel™ and SAFER@WORK™ programs which provide an early warning of the presence of SARS-CoV-2 amongst large populations or at a given site (e.g. a city, factories, education institutions, government and public service sites, nursing homes), before the virus spreads too broadly.

The monitoring of wastewater, environmental surface, air and worn mask testing can give an early indication of the presence of SARS-CoV-2 and can also detect virus variants. This allows for relevant containment measures to be put in place to avoid an outbreak of the disease even before symptom onset.

With a new VIRType kit, Eurofins is now able to rapidly detect and identify between the original SARS-CoV-2 strain (Wildtype) or known variants of interest including the UK (lineage B.1.1.7), South Africa (lineage B.1.351) or Brazil (lineage P.1) variants in wastewater, air, environmental surfaces and worn masks via RT-qPCR. Single point mutations referring to the UK / South Africa / Brazil lineages help to distinguish between the original strain and these SARS-CoV-2 variants.

The Eurofins COVID-19 Sentinel™ program is successfully being used in many countries and communities worldwide as an early and cost-effective indicator of virus presence. In the US, in addition to qualitative surface and worn mask testing the quantification of SARS-CoV-2 in wastewater and air provides crucial information for monitoring viral spread.

For more information, please visit the Eurofins SAFER@WORK website.

About Eurofins – the global leader in bio-analysis

Eurofins is Testing for Life. With over 50,000 staff across a network of more than 800 laboratories in over 50 countries, Eurofins’ companies offer a portfolio of over 200,000 analytical methods.

Eurofins Shares are listed on Euronext Paris Stock Exchange.

Contacts

Eurofins Scientific

BOURSE:ERF

Release Versions

Contacts

More News From Eurofins Scientific

Eurofins Biomnis Launches New Clinical LC‑MS/MS Method for the Detection of Cereulide Toxin in Stool Samples

LYON, France--(BUSINESS WIRE)--Eurofins Biomnis, a leading European provider of specialised clinical diagnostics services, and part of the global network of Eurofins laboratories, announces the successful development and validation of a new liquid chromatography tandem mass spectrometry (LC‑MS/MS) method for the detection and quantification of cereulide toxin in human stool samples. This innovation underlines Eurofins Biomnis’ diagnostic innovation, and its commitment to contributing its expert...

Eurofins Scientific SE: Weekly Report on Share Repurchases from 02nd March to 06th March 2026

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 02/03/2026 FR0014000MR3 30 000 67.7739 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 02/03/2026 FR0014000MR3 10 000 67.7248 CEUX EUROFINS SCIENTIFIC 529900JEHFM...

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 28 February 2026

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): ANNEXE B Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and grand-ducal regulation of 11 January 2008 on transparency requirements for issuers of securities 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedi (including the issuer ID allocated by the CSSF) EUROFINS SCIENTIFIC SE – E1013 2. Identi...
Back to Newsroom